This Steel Giant Is Up 28% in a Month With Earnings Estimates Still Climbing Higher

This week covers a steel name up 28% with estimates still climbing, a medical device story where segment strength is doing the heavy lifting despite a softer headline, and an auto components name up 120% over the past year with revisions still moving higher. 

If you want to know where industrial and healthcare momentum is actually building rather than guessing, this is the read.

Basic Materials

Nucor (NYSE: NUE) has climbed roughly 28% over the past month, and the story behind that move is not hype. Earnings estimates for fiscal 2026 now sit at $12.18 per share, up from where they were just a few months ago.

The company has averaged a 7.5% positive earnings surprise, which tells you execution has been running ahead of what analysts model.

Infrastructure spending, manufacturing reshoring, and domestic supply chain priorities are all feeding back into North American steel in a meaningful way.

Nucor has the scale to benefit directly from all three at the same time, and that combination is exactly what has been driving both the price and the estimate revisions higher together.

Earnings Estimates at $12.18

Moving the consensus to $12.18 while the stock is already climbing tells you both price and expectations are being revised upward simultaneously.

That combination tends to attract more momentum rather than slow it down, especially when the underlying demand drivers are structural rather than cyclical.

Reshoring and Infrastructure Spending

Domestic manufacturing activity and infrastructure investment are translating into real pricing power and shipment volume for North American steel producers.

Nucor has the scale and operational efficiency to capture that demand more effectively than smaller peers, which is why the stock tends to move first when industrial confidence improves.

Healthcare Devices

Integer Holdings (NYSE: ITGR) delivered a quarter that looks mixed on the surface but is more nuanced beneath the surface. Revenue came in at $439.6 million, up 0.5% year over year and beating expectations by just over 3%. Earnings per share fell to $1.20 from $1.31 a year ago, which is where the pressure sits.

The segment detail is more encouraging than the headline. Cardiac rhythm and neuromodulation sales grew nearly 5% year over year to $168.3 million. Cardiovascular revenue also came in slightly ahead of expectations at $261.7 million.

Not every part of the business is performing equally well, but the core medical device segments are holding up and, in some cases, pulling ahead of where analysts expected.

Demand Is Holding

A 0.5% top-line increase sounds modest, but beating expectations by 3% on that same number tells a more useful story. 

Demand is not deteriorating; it is just growing slowly, and the beat tells you the underlying business is performing ahead of what analysts were modeling.

Cardiac and Cardiovascular Segments

Cardiac rhythm and neuromodulation at $168.3 million, up nearly 5% year over year, and cardiovascular revenue ahead of expectations at $261.7 million are the two segments doing the work. 

Those are the parts of the business with the most durable demand profile, and they are outperforming even as other areas create headline pressure.

Auto Components

Garrett Motion (NASDAQ: GTX) has been on a run that does not look like it is slowing down. The stock is up about 23% over the past week and roughly 36% over the past month. Over the past year, gains have stacked up to more than 120%. 

What makes the move stand out is that the broader auto components space has actually been weaker over the same stretch. This is not a sector lift carrying the stock higher. It is stock-specific momentum doing the work on its own. Earnings expectations are reinforcing the price action rather than just following it.

Price Outperformance vs. Auto Components Sector

The broader auto components group has been under pressure over the same windows where Garrett has been surging. 

That contrast matters because it confirms the momentum is coming from inside the business and not from a tailwind lifting the whole space. Stock-specific momentum at this scale tends to be more durable than sector-driven moves.

Structural Support of the Uptrend

A steady upward revision in forward earnings tells you analysts are actively upgrading their view of what the business can deliver. 

That kind of shifting expectation tends to matter more over time than any single quarterly beat because it signals a changing baseline rather than a one-off result.

FNB Corp (NYSE: FNB) is one of the more compelling low-key setups in financials right now. It trades at roughly 10x forward earnings while many peers in the sector have already been rerated significantly higher, and you still get a dividend yield in the mid-5% range on top of that.

The stock is up about 5% over the past quarter, showing steady and controlled price movement rather than an overextended momentum run. Earnings stability is doing exactly what it needs to do to support that payout, which keeps the setup from looking fragile.

The combination of a cheap multiple, reliable income, and gradual price strength is genuinely hard to find in financials right now.

Flex Ltd (NASDAQ: FLEX) is one of the most interesting restructuring stories in the market after a 40% rally over the past 30 days, driven by strong earnings and a cleaner path forward through its planned Cloud and Power Infrastructure spin-off.

Revenue came in at roughly $7.5 billion with net income near $250 million, showing real scale alongside a business mix that is actively shifting toward higher-growth AI and power systems. The stock trades at about 41x earnings, below some peer averages near 53x, which keeps the valuation debate alive and interesting.

For you, this is the rare kind of name where momentum is already visible, and the fundamental story is still being written at the same time.

Vista Energy (NYSE: VIST) is one of the cleanest momentum setups on this week’s list, and it is not close. The stock is up about 30% over the past 12 weeks and roughly 7% in the last month, which tells you the trend is strengthening rather than running out of steam after an extended move.

It is also trading near 90% of its 52-week range, putting it right at the edge of potential breakout territory. Sustained price momentum alongside improving earnings sentiment is the combination that keeps a trend running rather than reversing, and that is exactly what you are looking at here.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any [blank] stocks you want me to check out.

Best Regards,
—Noah Zelvis
Undervalued Edge